Advanced BioMedical Technologies (Advanced BioMedical Technologies) 3-Year RORE % : 0.00% (As of Jul. 2021)

Advanced BioMedical Technologies 3-Year RORE % Chart

Advanced BioMedical Technologies Annual Data
	Trend	Oct11	Oct12	Oct13	Oct14	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20
3-Year RORE %		Get a 7-Day Free Trial					-	-	-	-	-

Advanced BioMedical Technologies Quarterly Data
	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21
3-Year RORE %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Advanced BioMedical Technologies's 3-Year RORE %

For the Medical Devices subindustry, Advanced BioMedical Technologies's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced BioMedical Technologies's 3-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's 3-Year RORE % falls into.

Advanced BioMedical Technologies 3-Year RORE % Calculation

Advanced BioMedical Technologies's 3-Year RORE % for the quarter that ended in Jul. 2021 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jul. 2021 and 3-year before.

Advanced BioMedical Technologies  (OTCPK:ABMT) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.

Advanced BioMedical Technologies 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Advanced BioMedical Technologies's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Business Description